高级检索
当前位置: 首页 > 详情页

Pharmacokinetics, bioavailability and metabolism of neferine in rat by LC-MS/MS and LC-HRMS

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Wuhan Jinyintan Hosp, Ctr Translat Med, Wuhan, Hubei, Peoples R China [2]Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Gen Surg, Sch Med, Shanghai, Peoples R China [3]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Surg, Wuhan, Peoples R China [4]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hepat Surg, Tongji Med Coll, Wuhan 430030, Peoples R China [5]Huazhong Univ Sci Technol, Tongji Med Coll, Dept Gerontol, Tongji Hosp, Wuhan, Peoples R China [6]Huazhong Univ Sci Technol, Tongji Med Coll, Dept Surg, Tongji Hosp, Wuhan, Peoples R China
出处:
ISSN:

关键词: bioavailability liver microsomes metabolite characterization neferine pharmacokinetics

摘要:
In this study, a simple and sensitive analytical method based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed and validated for the determination of neferine in rat plasma. After acetonitrile-mediated protein precipitation, the samples were separated on an Acquity BEH C-18 column (2.1 x 50 mm, 1.7 mu m) maintained at 40 degrees C. The mobile phase comprising 0.1% formic acid in water and acetonitrile was delivered at a flow rate of 0.4 ml/min. The mass detection was conducted using multiple reaction monitoring mode with ion transitions at 625.4 > 206.3 and m/z 622.9 > 380.9 for neferine and internal standard, respectively. The assay was demonstrated to be linear over the concentration range of 0.5-1,000 ng/ml, with correlation coefficient >0.999 (r > 0.999). The validated method was further applied to the pharmacokinetic study of neferine in rat plasma. In addition, the metabolism of neferine was investigated using high-resolution mass spectrometry. A total of six metabolites from rat liver microsomes and plasma were detected and their structures were identified according to their fragment ions. The proposed metabolic pathways of neferine were demethylation, dealkylation, dehydrogenation and glucuronidation.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 生化研究方法 4 区 生化与分子生物学 4 区 分析化学 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 生化研究方法 4 区 生化与分子生物学 4 区 分析化学 4 区 药学
JCR分区:
出版当年[2019]版:
Q3 CHEMISTRY, ANALYTICAL Q4 BIOCHEMICAL RESEARCH METHODS Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Q4 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q3 CHEMISTRY, ANALYTICAL Q3 PHARMACOLOGY & PHARMACY Q4 BIOCHEMICAL RESEARCH METHODS Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Wuhan Jinyintan Hosp, Ctr Translat Med, Wuhan, Hubei, Peoples R China
通讯作者:
通讯机构: [5]Huazhong Univ Sci Technol, Tongji Med Coll, Dept Gerontol, Tongji Hosp, Wuhan, Peoples R China [6]Huazhong Univ Sci Technol, Tongji Med Coll, Dept Surg, Tongji Hosp, Wuhan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:2 总访问量:410 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)